Supporting Online Material Materials and Methods Figs. S1 to S8 Tables S1 to S10 References a Genome-wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants
Supporting Online Material Materials and Methods Figs. S1 to S8 Tables S1 to S10 References a Genome-wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants
复制标题
DOI:
--
复制
发表时间:
--
期刊:
影响因子:
--
通讯作者:
S. Thomas;L. Scott;K. Mohlke;L. Bonnycastle;C. Willer;Yun Li;W. Duren;M. Erdos;H. Stringham
中科院分区:
文献类型:
--
作者:
S. Thomas;L. Scott;K. Mohlke;L. Bonnycastle;C. Willer;Yun Li;W. Duren;M. Erdos;H. Stringham
Identifying the genetic variants that increase the risk of type 2 diabetes (T2D) in humans has been a formidable challenge. Adopting a genome-wide association strategy, we genotyped 1161 Finnish T2D cases and 1174 Finnish normal glucose-tolerant (NGT) controls with >315,000 single-nucleotide polymorphisms (SNPs) and imputed genotypes for an additional >2 million autosomal SNPs. We carried out association analysis with these SNPs to identify genetic variants that predispose to T2D, compared our T2D association results with the results of two similar studies, and genotyped 80 SNPs in an additional 1215 Finnish T2D cases and 1258 Finnish NGT controls. We identify T2D-associated variants in an intergenic region of chromosome 11p12, contribute to the identification of T2D-associated variants near the genes IGF2BP2 and CDKAL1 and the region of CDKN2A and CDKN2B, and confirm that variants near TCF7L2, SLC30A8, HHEX, FTO, PPARG, and KCNJ11 are associated with T2D risk. This brings the number of T2D loci now confidently identified to at least 10. T ype 2 diabetes (T2D) is a disease characterized by insulin resistance and impaired pancreatic beta-cell function that affects >170 million people worldwide (1). With first-degree relatives having ~3.5 times as much risk as compared to individuals in the general middle-aged population (2), hereditary factors, together with lifestyle and behavioral factors, play an important role in determining T2D risk (3). To date, intense efforts to identify genetic risk factors in T2D have met with only limited success. This study, reports from our collaborators (4–6), and the recently published work of Sladek et al. (7) describe results of genome-wide association (GWA) studies that further define the genetic architecture of T2D and identify biological pathways involved in T2D pathogenesis. had ≥10 copies of the less common allele [minor allele frequency (MAF) > 0.002] and passed quality-control criteria (8). We tested these 315,635 SNPs for association with T2D using a model that is additive on the log-odds scale (Table 1 and tables S3 and S4) (8). We observed a modest excess (41 observed versus 31.6 expected; P = 0.19) of SNPs with P values < 10 −4 (fig. S1). These results argue against the existence of multiple common SNPs with a large impact on T2D disease risk but are consistent with the presence of multiple common SNPs that each confer modest risk. The results also suggest that the matching of cases and controls by birth province, sex, and age (8) has been successful; in …